Global Orphan Drugs Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Orphan Drugs Market Size 2017-2028

2.1.2 Orphan Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Orphan Drugs Segment by Type

2.2.1 Oncology

2.2.2 Pulmonary

2.2.3 Neurology

2.2.4 Hematology

2.2.5 Endocrinology

2.2.6 Cardio-vascular

2.2.7 Metabolic Disorders

2.2.8 Others

2.3 Orphan Drugs Market Size by Type

2.3.1 Orphan Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Orphan Drugs Market Size Market Share by Type (2017-2022)

2.4 Orphan Drugs Segment by End Users

2.4.1 Baby and Child

2.4.2 Teenager

2.4.3 Adult

2.4.4 Other

2.5 Orphan Drugs Market Size by End Users

2.5.1 Orphan Drugs Market Size CAGR by End Users (2017 VS 2022 VS 2028)

2.5.2 Global Orphan Drugs Market Size Market Share by End Users (2017-2022)

3 Orphan Drugs Market Size by Player

3.1 Orphan Drugs Market Size Market Share by Players

3.1.1 Global Orphan Drugs Revenue by Players (2020-2022)

3.1.2 Global Orphan Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Orphan Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Orphan Drugs by Regions

4.1 Orphan Drugs Market Size by Regions (2017-2022)

4.2 Americas Orphan Drugs Market Size Growth (2017-2022)

4.3 APAC Orphan Drugs Market Size Growth (2017-2022)

4.4 Europe Orphan Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Orphan Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Orphan Drugs Market Size by Country (2017-2022)

5.2 Americas Orphan Drugs Market Size by Type (2017-2022)

5.3 Americas Orphan Drugs Market Size by End Users (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Orphan Drugs Market Size by Region (2017-2022)

6.2 APAC Orphan Drugs Market Size by Type (2017-2022)

6.3 APAC Orphan Drugs Market Size by End Users (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Orphan Drugs by Country (2017-2022)

7.2 Europe Orphan Drugs Market Size by Type (2017-2022)

7.3 Europe Orphan Drugs Market Size by End Users (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Orphan Drugs by Region (2017-2022)

8.2 Middle East & Africa Orphan Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Orphan Drugs Market Size by End Users (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Orphan Drugs Market Forecast

10.1 Global Orphan Drugs Forecast by Regions (2023-2028)

10.1.1 Global Orphan Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Orphan Drugs Forecast

10.1.3 APAC Orphan Drugs Forecast

10.1.4 Europe Orphan Drugs Forecast

10.1.5 Middle East & Africa Orphan Drugs Forecast

10.2 Americas Orphan Drugs Forecast by Country (2023-2028)

10.2.1 United States Orphan Drugs Market Forecast

10.2.2 Canada Orphan Drugs Market Forecast

10.2.3 Mexico Orphan Drugs Market Forecast

10.2.4 Brazil Orphan Drugs Market Forecast

10.3 APAC Orphan Drugs Forecast by Region (2023-2028)

10.3.1 China Orphan Drugs Market Forecast

10.3.2 Japan Orphan Drugs Market Forecast

10.3.3 Korea Orphan Drugs Market Forecast

10.3.4 Southeast Asia Orphan Drugs Market Forecast

10.3.5 India Orphan Drugs Market Forecast

10.3.6 Australia Orphan Drugs Market Forecast

10.4 Europe Orphan Drugs Forecast by Country (2023-2028)

10.4.1 Germany Orphan Drugs Market Forecast

10.4.2 France Orphan Drugs Market Forecast

10.4.3 UK Orphan Drugs Market Forecast

10.4.4 Italy Orphan Drugs Market Forecast

10.4.5 Russia Orphan Drugs Market Forecast

10.5 Middle East & Africa Orphan Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Orphan Drugs Market Forecast

10.5.2 South Africa Orphan Drugs Market Forecast

10.5.3 Israel Orphan Drugs Market Forecast

10.5.4 Turkey Orphan Drugs Market Forecast

10.5.5 GCC Countries Orphan Drugs Market Forecast

10.6 Global Orphan Drugs Forecast by Type (2023-2028)

10.7 Global Orphan Drugs Forecast by End Users (2023-2028)

11 Key Players Analysis

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Information

11.1.2 Bristol-Myers Squibb Orphan Drugs Product Offered

11.1.3 Bristol-Myers Squibb Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bristol-Myers Squibb Main Business Overview

11.1.5 Bristol-Myers Squibb Latest Developments

11.2 Roche

11.2.1 Roche Company Information

11.2.2 Roche Orphan Drugs Product Offered

11.2.3 Roche Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Roche Main Business Overview

11.2.5 Roche Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Orphan Drugs Product Offered

11.3.3 Novartis Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Orphan Drugs Product Offered

11.4.3 Johnson & Johnson Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Johnson & Johnson Main Business Overview

11.4.5 Johnson & Johnson Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Orphan Drugs Product Offered

11.5.3 Pfizer Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 Amgen

11.6.1 Amgen Company Information

11.6.2 Amgen Orphan Drugs Product Offered

11.6.3 Amgen Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Amgen Main Business Overview

11.6.5 Amgen Latest Developments

11.7 Sanofi

11.7.1 Sanofi Company Information

11.7.2 Sanofi Orphan Drugs Product Offered

11.7.3 Sanofi Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Sanofi Main Business Overview

11.7.5 Sanofi Latest Developments

11.8 AstraZeneca

11.8.1 AstraZeneca Company Information

11.8.2 AstraZeneca Orphan Drugs Product Offered

11.8.3 AstraZeneca Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 AstraZeneca Main Business Overview

11.8.5 AstraZeneca Latest Developments

11.9 Takeda

11.9.1 Takeda Company Information

11.9.2 Takeda Orphan Drugs Product Offered

11.9.3 Takeda Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Takeda Main Business Overview

11.9.5 Takeda Latest Developments

11.10 Vertex Pharmaceuticals

11.10.1 Vertex Pharmaceuticals Company Information

11.10.2 Vertex Pharmaceuticals Orphan Drugs Product Offered

11.10.3 Vertex Pharmaceuticals Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Vertex Pharmaceuticals Main Business Overview

11.10.5 Vertex Pharmaceuticals Latest Developments

11.11 AbbVie

11.11.1 AbbVie Company Information

11.11.2 AbbVie Orphan Drugs Product Offered

11.11.3 AbbVie Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 AbbVie Main Business Overview

11.11.5 AbbVie Latest Developments

11.12 Biogen

11.12.1 Biogen Company Information

11.12.2 Biogen Orphan Drugs Product Offered

11.12.3 Biogen Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Biogen Main Business Overview

11.12.5 Biogen Latest Developments

11.13 Eli Lilly

11.13.1 Eli Lilly Company Information

11.13.2 Eli Lilly Orphan Drugs Product Offered

11.13.3 Eli Lilly Orphan Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Eli Lilly Main Business Overview

11.13.5 Eli Lilly Latest Developments

12 Research Findings and Conclusion

Table 1. Orphan Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oncology

Table 3. Major Players of Pulmonary

Table 4. Major Players of Neurology

Table 5. Major Players of Hematology

Table 6. Major Players of Endocrinology

Table 7. Major Players of Cardio-vascular

Table 8. Major Players of Metabolic Disorders

Table 9. Major Players of Others

Table 10. Orphan Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Orphan Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Orphan Drugs Market Size Market Share by Type (2017-2022)

Table 13. Orphan Drugs Market Size CAGR by End Users (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Orphan Drugs Market Size by End Users (2017-2022) & ($ Millions)

Table 15. Global Orphan Drugs Market Size Market Share by End Users (2017-2022)

Table 16. Global Orphan Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Orphan Drugs Revenue Market Share by Player (2020-2022)

Table 18. Orphan Drugs Key Players Head office and Products Offered

Table 19. Orphan Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Orphan Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Orphan Drugs Market Size Market Share by Regions (2017-2022)

Table 24. Americas Orphan Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Orphan Drugs Market Size Market Share by Country (2017-2022)

Table 26. Americas Orphan Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Orphan Drugs Market Size Market Share by Type (2017-2022)

Table 28. Americas Orphan Drugs Market Size by End Users (2017-2022) & ($ Millions)

Table 29. Americas Orphan Drugs Market Size Market Share by End Users (2017-2022)

Table 30. APAC Orphan Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Orphan Drugs Market Size Market Share by Region (2017-2022)

Table 32. APAC Orphan Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Orphan Drugs Market Size Market Share by Type (2017-2022)

Table 34. APAC Orphan Drugs Market Size by End Users (2017-2022) & ($ Millions)

Table 35. APAC Orphan Drugs Market Size Market Share by End Users (2017-2022)

Table 36. Europe Orphan Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Orphan Drugs Market Size Market Share by Country (2017-2022)

Table 38. Europe Orphan Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Orphan Drugs Market Size Market Share by Type (2017-2022)

Table 40. Europe Orphan Drugs Market Size by End Users (2017-2022) & ($ Millions)

Table 41. Europe Orphan Drugs Market Size Market Share by End Users (2017-2022)

Table 42. Middle East & Africa Orphan Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Orphan Drugs Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Orphan Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Orphan Drugs Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Orphan Drugs Market Size by End Users (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Orphan Drugs Market Size Market Share by End Users (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Orphan Drugs

Table 49. Key Market Challenges & Risks of Orphan Drugs

Table 50. Key Industry Trends of Orphan Drugs

Table 51. Global Orphan Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Orphan Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Orphan Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Orphan Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Orphan Drugs Market Size Forecast by End Users (2023-2028) & ($ Millions)

Table 56. Global Orphan Drugs Market Size Market Share Forecast by End Users (2023-2028)

Table 57. Bristol-Myers Squibb Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 58. Bristol-Myers Squibb Orphan Drugs Product Offered

Table 59. Bristol-Myers Squibb Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Bristol-Myers Squibb Main Business

Table 61. Bristol-Myers Squibb Latest Developments

Table 62. Roche Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 63. Roche Orphan Drugs Product Offered

Table 64. Roche Main Business

Table 65. Roche Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Roche Latest Developments

Table 67. Novartis Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 68. Novartis Orphan Drugs Product Offered

Table 69. Novartis Main Business

Table 70. Novartis Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Novartis Latest Developments

Table 72. Johnson & Johnson Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 73. Johnson & Johnson Orphan Drugs Product Offered

Table 74. Johnson & Johnson Main Business

Table 75. Johnson & Johnson Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Johnson & Johnson Latest Developments

Table 77. Pfizer Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 78. Pfizer Orphan Drugs Product Offered

Table 79. Pfizer Main Business

Table 80. Pfizer Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Pfizer Latest Developments

Table 82. Amgen Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 83. Amgen Orphan Drugs Product Offered

Table 84. Amgen Main Business

Table 85. Amgen Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Amgen Latest Developments

Table 87. Sanofi Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 88. Sanofi Orphan Drugs Product Offered

Table 89. Sanofi Main Business

Table 90. Sanofi Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Sanofi Latest Developments

Table 92. AstraZeneca Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 93. AstraZeneca Orphan Drugs Product Offered

Table 94. AstraZeneca Main Business

Table 95. AstraZeneca Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. AstraZeneca Latest Developments

Table 97. Takeda Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 98. Takeda Orphan Drugs Product Offered

Table 99. Takeda Main Business

Table 100. Takeda Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Takeda Latest Developments

Table 102. Vertex Pharmaceuticals Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 103. Vertex Pharmaceuticals Orphan Drugs Product Offered

Table 104. Vertex Pharmaceuticals Main Business

Table 105. Vertex Pharmaceuticals Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Vertex Pharmaceuticals Latest Developments

Table 107. AbbVie Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 108. AbbVie Orphan Drugs Product Offered

Table 109. AbbVie Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. AbbVie Main Business

Table 111. AbbVie Latest Developments

Table 112. Biogen Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 113. Biogen Orphan Drugs Product Offered

Table 114. Biogen Main Business

Table 115. Biogen Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Biogen Latest Developments

Table 117. Eli Lilly Details, Company Type, Orphan Drugs Area Served and Its Competitors

Table 118. Eli Lilly Orphan Drugs Product Offered

Table 119. Eli Lilly Main Business

Table 120. Eli Lilly Orphan Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Eli Lilly Latest Developments

List of Figures

Figure 1. Orphan Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Orphan Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Orphan Drugs Market Size Market Share by Type in 2021

Figure 7. Orphan Drugs in Baby and Child

Figure 8. Global Orphan Drugs Market: Baby and Child (2017-2022) & ($ Millions)

Figure 9. Orphan Drugs in Teenager

Figure 10. Global Orphan Drugs Market: Teenager (2017-2022) & ($ Millions)

Figure 11. Orphan Drugs in Adult

Figure 12. Global Orphan Drugs Market: Adult (2017-2022) & ($ Millions)

Figure 13. Orphan Drugs in Other

Figure 14. Global Orphan Drugs Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Orphan Drugs Market Size Market Share by End Users in 2021

Figure 16. Global Orphan Drugs Revenue Market Share by Player in 2021

Figure 17. Global Orphan Drugs Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Orphan Drugs Market Size 2017-2022 ($ Millions)

Figure 19. APAC Orphan Drugs Market Size 2017-2022 ($ Millions)

Figure 20. Europe Orphan Drugs Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Orphan Drugs Market Size 2017-2022 ($ Millions)

Figure 22. Americas Orphan Drugs Value Market Share by Country in 2021

Figure 23. Americas Orphan Drugs Consumption Market Share by Type in 2021

Figure 24. Americas Orphan Drugs Market Size Market Share by End Users in 2021

Figure 25. United States Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Orphan Drugs Market Size Market Share by Region in 2021

Figure 30. APAC Orphan Drugs Market Size Market Share by End Users in 2021

Figure 31. China Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Orphan Drugs Market Size Market Share by Country in 2021

Figure 38. Europe Orphan Drugs Market Size Market Share by Type in 2021

Figure 39. Europe Orphan Drugs Market Size Market Share by End Users in 2021

Figure 40. Germany Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Orphan Drugs Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Orphan Drugs Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Orphan Drugs Market Size Market Share by End Users in 2021

Figure 48. Egypt Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Orphan Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 54. APAC Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 55. Europe Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 57. United States Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Canada Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 61. China Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Japan Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 63. Korea Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 65. India Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Australia Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 67. Germany Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 68. France Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 69. UK Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 70. Italy Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 71. Russia Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Spain Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 75. Israel Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Orphan Drugs Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Orphan Drugs Market Size 2023-2028 ($ Millions)